Diet-microbe interactions modulating host energy balance
饮食-微生物相互作用调节宿主能量平衡
基本信息
- 批准号:10478121
- 负责人:
- 金额:$ 24.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:Acute DiseaseAdultAdvisory CommitteesAffectAmericasAnimalsAntibioticsAwardBile Acid Biosynthesis PathwayBile AcidsBody Weight decreasedBody fatCaloric RestrictionCaloriesCell Culture TechniquesCell physiologyCenters for Disease Control and Prevention (U.S.)ChildClostridium difficileCommunicable DiseasesCommunitiesDataDevelopmentDiagnosticDietDietary InterventionDiseaseEcologyEnergy IntakeEnergy MetabolismEnvironmentEnvironmental Risk FactorGastrointestinal tract structureGene Expression ProfileGerm-FreeGnotobioticGoalsHealthHumanIndividualInfectionInterventionIntestinesKnock-outLinkMacronutrients NutritionMeasuresMetabolicMetabolic DiseasesMetabolismMetagenomicsMethodological StudiesMethodsMicrobeModelingMonitorMusNon-Insulin-Dependent Diabetes MellitusNutrientObesityOrganismOrganoidsPathogenesisPathogenicityPhasePhenotypePlayPopulationPositioning AttributePreventionPublic HealthQuality of lifeReproduction sporesResearchRoleShotgunsStrokeStructureSystemTestingToxic effectToxinTrainingUnited StatesWorkantibiotic-associated diarrheabasebile acid metabolismclinical practicecombinatorialcostdesigndiet-induced obesityenergy balanceexperimental studyfecal transplantationglucose tolerancegut microbiomegut microbiotaheart disease riskhost-microbe interactionshuman subjecthumanized mousein vitro Modelintestinal epitheliumintestinal homeostasismembermetabolomicsmicrobialmicrobial communitymicrobiomemicrobiome researchmicrobiotamouse modelmutantnew therapeutic targetnovelnovel therapeutic interventionnutrient absorptionnutritionpathobiontpathogenpost-transplantprogramsreconstructionskillsuptakeweight maintenance
项目摘要
PROJECT SUMMARY/ABSTRACT
Obesity affects approximately 35% of adults and 17% of children in the United States increasing the risks of
heart disease, stroke and type 2 diabetes. The human gut microbiota, the trillions of microbes that inhabit the
gastrointestinal tract, have been implicated as an environmental factor linked to obesity and energy balance;
however, the mechanisms are not fully understood. Diet remains the first line intervention to induce weight
loss, but its impact on the microbiota, and how this may affect weight loss and regain remain unclear. My
preliminary results from a very-low calorie diet intervention in human subjects reveal that caloric restriction
induces antibiotic-like disturbances in microbiota composition and function. Fecal transplant from post-diet
humans to germ-free mice induces weight loss. Analysis of both human and mouse microbiotas revealed that
the diet-induced reconfiguration of the microbiota allowed for expansion of Clostridioides [Clostridium] difficile,
best known as a major cause of antibiotic-associated diarrhea and its severe complications. In a colonization
model, C. difficile was sufficient to drive weight loss, reduce body fat, and increase glucose tolerance without
causing acute disease. These observations have led to the hypothesis that diet interactions with the gut
microbiota and C. difficile disrupt nutrient uptake contributing to energy imbalance. The first aim of these
studies will focus on the ability of C. difficile to affect host energy balance while characterizing the mechanisms
through which it occurs. Preliminary data strongly implicates the C. difficile toxins TcdA and/or TcdB. Using
combinatorial and individual knockouts, the causative toxin will be identified and its effects on host energy
balance will be extensively characterized. To define the mechanisms through which C. difficile acts at the level
of the intestinal epithelium, the effect of sub-toxic purified toxin(s) on nutrient absorption and cell physiology will
be examined in organoid models of both the human and mouse intestine. Finally, the ability of asymptomatic
colonization to counter diet-induced obesity will be examined. The second aim of this work will examine the
mechanism through which caloric restriction affects C. difficile permissibility. Specifically, this aim will test the
hypothesis that caloric restriction depletes microbes that produce C. difficile-inhibitory secondary bile acids.
Through a humanized mouse model of caloric restriction, and sequence-guided isolation and metabolic
characterization, synthetic communities will be designed replicating diet-responsive microbes to specifically
test the role of secondary bile acid biosynthesis, and potentially identify new antagonistic interactions which are
of great relevance to C. difficile treatment and prevention. The proposed experiments in these aims will
leverage my expertise in the microbiome field with new training in obesity and metabolic disease research. An
expert interdisciplinary advisory committee, and an institutional focus on microbiome and metabolism research,
will provide the ideal environment for the proposed scientific and professional development leading to the
creation of an independent research program.
项目概要/摘要
在美国,肥胖影响着大约 35% 的成年人和 17% 的儿童,增加了肥胖的风险
心脏病、中风和 2 型糖尿病。人类肠道微生物群,栖息在肠道中的数万亿微生物
胃肠道,被认为是与肥胖和能量平衡相关的环境因素;
然而,其机制尚不完全清楚。饮食仍然是诱导体重的一线干预措施
体重减轻,但它对微生物群的影响,以及这如何影响体重减轻和恢复仍不清楚。我的
对人类受试者进行极低热量饮食干预的初步结果表明,热量限制
引起微生物群组成和功能的抗生素样干扰。饮食后粪便移植
人类对无菌小鼠的研究会导致体重减轻。对人类和小鼠微生物群的分析表明
饮食诱导的微生物群重组使得艰难梭菌 [Clostridium] difficile 得以扩张,
众所周知,它是抗生素相关性腹泻及其严重并发症的主要原因。在殖民时期
模型中,艰难梭菌足以推动体重减轻、减少体内脂肪并增加葡萄糖耐量,而无需
引起急性疾病。这些观察结果得出这样的假设:饮食与肠道相互作用
微生物群和艰难梭菌会破坏营养吸收,导致能量失衡。这些的第一个目标
研究将重点关注艰难梭菌影响宿主能量平衡的能力,同时表征其机制
它通过它发生。初步数据强烈暗示艰难梭菌毒素 TcdA 和/或 TcdB。使用
组合和个体敲除,将识别致病毒素及其对宿主能量的影响
平衡将得到广泛的表征。定义艰难梭菌在水平上发挥作用的机制
肠上皮细胞的亚毒性纯化毒素对营养吸收和细胞生理学的影响将
在人类和小鼠肠道的类器官模型中进行检查。最后,无症状感染者的能力
将检查对抗饮食引起的肥胖的定植。这项工作的第二个目标将检查
热量限制影响艰难梭菌允许性的机制。具体而言,该目标将测试
假设热量限制会消耗产生艰难梭菌抑制性次级胆汁酸的微生物。
通过热量限制的人源化小鼠模型以及序列引导的分离和代谢
表征,合成群落将被设计复制饮食响应微生物,以专门
测试次级胆汁酸生物合成的作用,并可能识别新的拮抗相互作用
与艰难梭菌的治疗和预防密切相关。这些目标所提出的实验将
利用我在微生物组领域的专业知识与肥胖和代谢疾病研究方面的新培训。一个
跨学科专家咨询委员会,以及微生物组和代谢研究的机构重点,
将为拟议的科学和专业发展提供理想的环境,从而实现
创建独立的研究计划。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Bile acids and the gut microbiota: metabolic interactions and impacts on disease.
胆汁酸和肠道微生物群:代谢相互作用和对疾病的影响。
- DOI:
- 发表时间:2023-04
- 期刊:
- 影响因子:0
- 作者:Collins, Stephanie L;Stine, Jonathan G;Bisanz, Jordan E;Okafor, C Denise;Patterson, Andrew D
- 通讯作者:Patterson, Andrew D
Roles of the gut microbiome in weight management.
肠道微生物组在体重管理中的作用。
- DOI:
- 发表时间:2023-08
- 期刊:
- 影响因子:0
- 作者:Carmody, Rachel N;Bisanz, Jordan E
- 通讯作者:Bisanz, Jordan E
Meta-organismal metabolism in cardiovascular disease.
心血管疾病中的元有机代谢。
- DOI:10.1016/j.chom.2022.12.007
- 发表时间:2023-01-01
- 期刊:
- 影响因子:30.3
- 作者:Min Soo Kim;J. Bisanz
- 通讯作者:J. Bisanz
Making gut microbiomes from scratch.
从头开始制作肠道微生物组。
- DOI:
- 发表时间:2022-11-09
- 期刊:
- 影响因子:30.3
- 作者:Tian, Shuchang;Bisanz, Jordan E
- 通讯作者:Bisanz, Jordan E
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jordan Adam Bisanz其他文献
Jordan Adam Bisanz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jordan Adam Bisanz', 18)}}的其他基金
Decoding Microbial Diversity in the Human Gut Microbiome
解码人类肠道微生物组中的微生物多样性
- 批准号:
10713170 - 财政年份:2023
- 资助金额:
$ 24.87万 - 项目类别:
Diet-microbe interactions modulating host energy balance
饮食-微生物相互作用调节宿主能量平衡
- 批准号:
10435693 - 财政年份:2021
- 资助金额:
$ 24.87万 - 项目类别:
Diet-microbe interactions modulating host energy balance
饮食-微生物相互作用调节宿主能量平衡
- 批准号:
9976879 - 财政年份:2020
- 资助金额:
$ 24.87万 - 项目类别:
相似国自然基金
基于动态信息的深度学习辅助设计成人脊柱畸形手术方案的研究
- 批准号:82372499
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
单核细胞产生S100A8/A9放大中性粒细胞炎症反应调控成人Still病发病及病情演变的机制研究
- 批准号:82373465
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SERPINF1/SRSF6/B7-H3信号通路在成人B-ALL免疫逃逸中的作用及机制研究
- 批准号:82300208
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Function and Targeting of ETV6 in Ewing Sarcoma
ETV6 在尤文肉瘤中的功能和靶向
- 批准号:
10740562 - 财政年份:2023
- 资助金额:
$ 24.87万 - 项目类别:
Early life stress impacts molecular and network properties that bias the recruitment of pro-stress BLA circuits
早期生活压力会影响分子和网络特性,从而影响促压力 BLA 回路的募集
- 批准号:
10820820 - 财政年份:2023
- 资助金额:
$ 24.87万 - 项目类别:
Project 4: Off-the-shelf engineered cord blood-derived natural killer cells for the treatment acute lymphoblastic leukemia
项目 4:现成的工程化脐带血自然杀伤细胞,用于治疗急性淋巴细胞白血病
- 批准号:
10931069 - 财政年份:2023
- 资助金额:
$ 24.87万 - 项目类别:
Sickle cell disease gut dysbiosis effects on CNS pain processing
镰状细胞病肠道菌群失调对中枢神经系统疼痛处理的影响
- 批准号:
10747045 - 财政年份:2023
- 资助金额:
$ 24.87万 - 项目类别:
Temporospatial Single-Cell Characterization of Angiogenesis and Myocardial Regeneration in Small and Large Mammals
小型和大型哺乳动物血管生成和心肌再生的时空单细胞表征
- 批准号:
10751870 - 财政年份:2023
- 资助金额:
$ 24.87万 - 项目类别: